Apollo
metadata only
Closed‐loop technology: a practical guide
32-biomedical-and-clinical-sciences42-health-sciencesautoimmune-diseasebioengineeringclinical-researchdiabetes
Abstract Hybrid closed‐loop insulin delivery has been shown to be safe and effective in improving time in target glucose range and reducing the risk of hypoglycaemia for people with type 1 diabetes. Benefits in terms of reduction in diabetes burden have also been demonstrated. After decades of resea
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Impact of the Use of a Closed-loop Insulin Therapy on the Burden of the Diabetes and the Quality of Life#1161848
- Closed-loop Insulin Delivery in Pregnant Women With Type 1 Diabetes#1138308
- Use of an Automated Insulin Delivery System Compared to Sensor Augmented Pump at Patients With Type 1 Diabetes (T1D)#1150008
- Closed-loop Insulin Delivery Systems in Pancreatic Diabetes#1282892
- Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes#982168
Record · ID 1450989
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive